Drug composition for blood sugar control
First Claim
1. A pharmaceutical composition for glycemic control of a type II diabetic patient, which is prepared for administration before meal and comprises mitiglinide or a pharmaceutically acceptable salt thereof, or a hydrate thereof, wherein the amount to be administered as a single dose is 5 to 45 mg.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention provides pharmaceutical compositions which can achieve good state of glycemic control and correct postprandial hyperglycemia and early morning fasting hyperglycemia. The present pharmaceutical composition is for administration before meal to control blood glucose, which comprises 5 to 45 mg, as a single dose, of mitiglinide or a pharmaceutically acceptable salt thereof, or a hydrate thereof (for example, mitiglinide calcium salt hydrate). And said compositions are extremely useful for prevention or treatment of, for example, type II diabetes, because the frequency of adverse drug reactions such as hypoglycemic symptoms and gastrointestinal disorders is low.
-
Citations
23 Claims
- 1. A pharmaceutical composition for glycemic control of a type II diabetic patient, which is prepared for administration before meal and comprises mitiglinide or a pharmaceutically acceptable salt thereof, or a hydrate thereof, wherein the amount to be administered as a single dose is 5 to 45 mg.
-
10. A use of a pharmaceutical composition as claimed in claim for prevention or treatment of type II diabetes.
- 12. A method for glycemic control of a type II diabetic patient, which comprises administrating before meal 5 to 45 mg of mitiglinide or a pharmaceutically acceptable salt thereof, or a hydrate thereof, as a single dose.
- 16. A method for improvement of postprandial hyperglycemia of a type II diabetic patient, which comprises administrating before meal 5 to 45 mg of mitiglinide or a pharmaceutically acceptable salt thereof, or a hydrate thereof as a single dose.
-
21. (canceled)
Specification
-
- Resources
-
Current AssigneeKissei Pharmaceutical Company Limited
-
Original AssigneeKissei Pharmaceutical Company Limited
-
InventorsSuzuki, Hisao, Kiyono, Yuji, Mikoshiba, Imao
-
Application NumberUS10/519,102Publication NumberTime in Patent OfficeDaysField of SearchUS Class Current514/416CPC Class CodesA61K 31/4035 Isoindoles, e.g. phthalimideA61P 13/12 of the kidneysA61P 25/00 Drugs for disorders of the ...A61P 27/02 Ophthalmic agentsA61P 3/10 for hyperglycaemia, e.g. an...A61P 43/00 Drugs for specific purposes...A61P 9/10 for treating ischaemic or a...
